Sun Pharma, US-based Rockwell Medical enter into licensing pact for Triferic in India

As per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term of the agreement, subject to its approval in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ad1yzW
via IFTTT